| UniProt ID | MTMR1_HUMAN | |
|---|---|---|
| UniProt AC | Q13613 | |
| Protein Name | Myotubularin-related protein 1 | |
| Gene Name | MTMR1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 665 | |
| Subcellular Localization |
Cell membrane Peripheral membrane protein Cytoplasmic side . Cytoplasm . |
|
| Protein Description | Lipid phosphatase that has high specificity for phosphatidylinositol 3-phosphate and has no activity with phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate. [PubMed: 11733541] | |
| Protein Sequence | MDRPAAAAAAGCEGGGGPNPGPAGGRRPPRAAGGATAGSRQPSVETLDSPTGSHVEWCKQLIAATISSQISGSVTSENVSRDYKALRDGNKLAQMEEAPLFPGESIKAIVKDVMYICPFMGAVSGTLTVTDFKLYFKNVERDPHFILDVPLGVISRVEKIGAQSHGDNSCGIEIVCKDMRNLRLAYKQEEQSKLGIFENLNKHAFPLSNGQALFAFSYKEKFPINGWKVYDPVSEYKRQGLPNESWKISKINSNYEFCDTYPAIIVVPTSVKDDDLSKVAAFRAKGRVPVLSWIHPESQATITRCSQPLVGPNDKRCKEDEKYLQTIMDANAQSHKLIIFDARQNSVADTNKTKGGGYESESAYPNAELVFLEIHNIHVMRESLRKLKEIVYPSIDEARWLSNVDGTHWLEYIRMLLAGAVRIADKIESGKTSVVVHCSDGWDRTAQLTSLAMLMLDSYYRTIKGFETLVEKEWISFGHRFALRVGHGNDNHADADRSPIFLQFVDCVWQMTRQFPSAFEFNELFLITILDHLYSCLFGTFLCNCEQQRFKEDVYTKTISLWSYINSQLDEFSNPFFVNYENHVLYPVASLSHLELWVNYYVRWNPRMRPQMPIHQNLKELLAVRAELQKRVEGLQREVATRAVSSSSERGSSPSHSATSVHTSV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDRPAAAA -------CCCHHHHH | 9.95 | 22223895 | |
| 36 | Phosphorylation | PRAAGGATAGSRQPS CCCCCCCCCCCCCCC | 34.52 | 23927012 | |
| 39 | Phosphorylation | AGGATAGSRQPSVET CCCCCCCCCCCCCCC | 25.86 | 23927012 | |
| 43 | Phosphorylation | TAGSRQPSVETLDSP CCCCCCCCCCCCCCC | 25.01 | 23401153 | |
| 46 | Phosphorylation | SRQPSVETLDSPTGS CCCCCCCCCCCCCCH | 33.44 | 23927012 | |
| 49 | Phosphorylation | PSVETLDSPTGSHVE CCCCCCCCCCCHHHH | 27.72 | 25159151 | |
| 51 | Phosphorylation | VETLDSPTGSHVEWC CCCCCCCCCHHHHHH | 56.09 | 23927012 | |
| 53 | Phosphorylation | TLDSPTGSHVEWCKQ CCCCCCCHHHHHHHH | 27.17 | 23403867 | |
| 65 | Phosphorylation | CKQLIAATISSQISG HHHHHHHHHHHHCCC | 16.63 | 21406692 | |
| 67 | Phosphorylation | QLIAATISSQISGSV HHHHHHHHHHCCCCC | 16.31 | 21406692 | |
| 68 | Phosphorylation | LIAATISSQISGSVT HHHHHHHHHCCCCCC | 27.90 | 21406692 | |
| 71 | Phosphorylation | ATISSQISGSVTSEN HHHHHHCCCCCCCCC | 19.85 | 21406692 | |
| 73 | Phosphorylation | ISSQISGSVTSENVS HHHHCCCCCCCCCCC | 18.55 | 21406692 | |
| 75 | Phosphorylation | SQISGSVTSENVSRD HHCCCCCCCCCCCHH | 31.83 | 21406692 | |
| 76 | Phosphorylation | QISGSVTSENVSRDY HCCCCCCCCCCCHHH | 25.64 | 21406692 | |
| 80 | Phosphorylation | SVTSENVSRDYKALR CCCCCCCCHHHHHHH | 30.89 | 21406692 | |
| 91 (in isoform 2) | Ubiquitination | - | 51.21 | 21890473 | |
| 91 | Ubiquitination | KALRDGNKLAQMEEA HHHHCCCCCCCHHCC | 51.21 | 21906983 | |
| 91 (in isoform 1) | Ubiquitination | - | 51.21 | 21890473 | |
| 107 | Ubiquitination | LFPGESIKAIVKDVM CCCHHHHHHHHHHHH | 41.14 | - | |
| 115 | Phosphorylation | AIVKDVMYICPFMGA HHHHHHHHHHHCCCC | 10.14 | 21406692 | |
| 124 | Phosphorylation | CPFMGAVSGTLTVTD HHCCCCCCCEEEEEE | 26.06 | 21406692 | |
| 126 | Phosphorylation | FMGAVSGTLTVTDFK CCCCCCCEEEEEEEE | 16.26 | 21406692 | |
| 128 | Phosphorylation | GAVSGTLTVTDFKLY CCCCCEEEEEEEEEE | 22.61 | 21406692 | |
| 130 | Phosphorylation | VSGTLTVTDFKLYFK CCCEEEEEEEEEEEE | 30.40 | 21406692 | |
| 155 | Phosphorylation | DVPLGVISRVEKIGA ECCHHHHHHHHHHCC | 28.06 | 24719451 | |
| 159 | Ubiquitination | GVISRVEKIGAQSHG HHHHHHHHHCCCCCC | 43.51 | - | |
| 159 | Acetylation | GVISRVEKIGAQSHG HHHHHHHHHCCCCCC | 43.51 | 25953088 | |
| 177 | Ubiquitination | CGIEIVCKDMRNLRL CCEEEEEHHHHHCHH | 43.60 | - | |
| 186 | Phosphorylation | MRNLRLAYKQEEQSK HHHCHHHHHHHHHHH | 20.14 | 30622161 | |
| 187 | Ubiquitination | RNLRLAYKQEEQSKL HHCHHHHHHHHHHHH | 45.70 | - | |
| 192 | Phosphorylation | AYKQEEQSKLGIFEN HHHHHHHHHHCHHCC | 32.88 | 30622161 | |
| 193 | Ubiquitination | YKQEEQSKLGIFENL HHHHHHHHHCHHCCC | 50.88 | - | |
| 237 (in isoform 2) | Ubiquitination | - | 33.91 | 21890473 | |
| 237 | Acetylation | YDPVSEYKRQGLPNE ECCHHHHHHCCCCCC | 33.91 | 30590509 | |
| 237 (in isoform 1) | Ubiquitination | - | 33.91 | 21890473 | |
| 237 | Ubiquitination | YDPVSEYKRQGLPNE ECCHHHHHHCCCCCC | 33.91 | 21890473 | |
| 247 | Ubiquitination | GLPNESWKISKINSN CCCCCCCEEEECCCC | 46.51 | - | |
| 250 | Ubiquitination | NESWKISKINSNYEF CCCCEEEECCCCCCC | 49.75 | - | |
| 253 | Phosphorylation | WKISKINSNYEFCDT CEEEECCCCCCCCCC | 44.24 | - | |
| 278 | Ubiquitination | VKDDDLSKVAAFRAK CCCCCHHHHHHHHHC | 43.10 | - | |
| 292 | O-linked_Glycosylation | KGRVPVLSWIHPESQ CCCCCEEEEECHHHC | 24.99 | 30379171 | |
| 315 | Ubiquitination | PLVGPNDKRCKEDEK CCCCCCCCCCCCCHH | 67.35 | - | |
| 458 | Phosphorylation | LAMLMLDSYYRTIKG HHHHHHHHHHHHHCC | 21.80 | 25072903 | |
| 459 | Phosphorylation | AMLMLDSYYRTIKGF HHHHHHHHHHHHCCH | 9.16 | 25072903 | |
| 460 | Phosphorylation | MLMLDSYYRTIKGFE HHHHHHHHHHHCCHH | 12.77 | 25072903 | |
| 468 | Phosphorylation | RTIKGFETLVEKEWI HHHCCHHHHHHHHEC | 33.57 | - | |
| 555 | Phosphorylation | QRFKEDVYTKTISLW HHCHHCCCHHHHHHH | 18.16 | 25839225 | |
| 645 | Phosphorylation | EVATRAVSSSSERGS HHHHHHHCCCCCCCC | 24.42 | 24732914 | |
| 646 | Phosphorylation | VATRAVSSSSERGSS HHHHHHCCCCCCCCC | 31.14 | 24732914 | |
| 647 | Phosphorylation | ATRAVSSSSERGSSP HHHHHCCCCCCCCCC | 28.81 | 24732914 | |
| 648 | Phosphorylation | TRAVSSSSERGSSPS HHHHCCCCCCCCCCC | 33.01 | 24732914 | |
| 650 | Methylation | AVSSSSERGSSPSHS HHCCCCCCCCCCCCC | 52.84 | 115484057 | |
| 652 | Phosphorylation | SSSSERGSSPSHSAT CCCCCCCCCCCCCCC | 45.34 | 22167270 | |
| 653 | Phosphorylation | SSSERGSSPSHSATS CCCCCCCCCCCCCCC | 32.99 | 22167270 | |
| 655 | Phosphorylation | SERGSSPSHSATSVH CCCCCCCCCCCCCCC | 31.83 | 22167270 | |
| 657 | Phosphorylation | RGSSPSHSATSVHTS CCCCCCCCCCCCCCC | 37.26 | 22167270 | |
| 659 | Phosphorylation | SSPSHSATSVHTSV- CCCCCCCCCCCCCC- | 34.01 | 22167270 | |
| 660 | Phosphorylation | SPSHSATSVHTSV-- CCCCCCCCCCCCC-- | 16.18 | 22167270 | |
| 663 | Phosphorylation | HSATSVHTSV----- CCCCCCCCCC----- | 29.09 | 25159151 | |
| 664 | O-linked_Glycosylation | SATSVHTSV------ CCCCCCCCC------ | 15.79 | 30379171 | |
| 664 | Phosphorylation | SATSVHTSV------ CCCCCCCCC------ | 15.79 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTMR1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTMR1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTMR1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NADAP_HUMAN | SLC4A1AP | physical | 27880917 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |